How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

361 results for

bell's palsy guideline

Latest & greatest

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

81. Appropriate Use Criteria: Imaging of the Head & Neck

trigeminal neuralgia: a blinded case-control study and meta-analysis. Pain. 2014; 155(8):1464-1471. 9. Arab AF, Ahmed ME, Ahmed AE, et al. Accuracy of Canadian CT head rule in predicting positive findings on CT of the head of patients after mild head injury in a large trauma centre in Saudi Arabia. Neuroradiol J. 2015 Dec;28(6):591-7. 10. Baugh RF, Basura GJ, Ishii LE, et al. Clinical practice guideline: Bell’s palsy. Otolaryngol Head Neck Surg. 2013 Nov;149(3 Suppl):S1-S27. 11. Beck J, Raabe A, Szelenyi (...) is required to direct treatment Surveillance of established tumor CT Head | Copyright © 2018. AIM Specialty Health. All Rights Reserved. 9 Common Diagnostic Indications Neurologic Signs & Symptoms This section contains indications for Bell’s palsy, headache, mental status change, syncope, vertigo/dizziness, and visual disturbance. Advanced imaging based on nonspecific signs or symptoms is subject to a high level of clinical review . Appropriateness of imaging depends upon the context in which

2018 AIM Specialty Health

82. Trumenba - meningococcal group b vaccine (recombinant, adsorbed)

, in vitro Relative Antigenicity Method (IVRA), purity, protein concentration Assessment report EMA/CHMP/232746/2017 Page 16/139 determination, Polysorbate 80 (to calculate PS80 to protein molar ratio), residual DNA and residual host cell protein (HCP). The analytical methods used have been adequately described and non-compendial methods appropriately validated in accordance with ICH guidelines. A summary of all the analytical procedures and associated validation reports is provided. Batch analysis Batch (...) of a modified rabbit pyrogenicity test has been justified. Non-compendial methods are described in sufficient detail and validated in conformance with ICH guidelines. The in vivo potency assay (IVPA) is used to determine the immunogenicity of bivalent rLP2086 finished product. Batch analysis The batch analyses data for MnB bivalent rLP2086 finished product lots manufactured at full commercial scale have been provided. All data meet the specifications in place at the time of release. Stability of the product

2017 European Medicines Agency - EPARs

83. Quality measures in high-risk pregnancies: Executive summary of a cooperative workshop of SMFM, NICHD, and ACOG Full Text available with Trip Pro

measures for participant consideration as a quality measure: rationale for inclusion orexclusion (continued) Proposedmeasures Importance Scienti?cacceptability Usability Feasibility Recommended forfurther consideration or development Magnesium sulfate neuroprotection at 24e32 weeks of gestation Yes Current standard of ACOG and SMFM Yes Meta-analyses demonstrate decreased moderate-severe cerebral palsy or death. Unclear Rare outcome, multifactorial causes Unclear Some concern exists about proper (...) majorityofwomenwithpreeclampsiawithseverefeatures. Low-dose aspirin. Prevention of hypertensive disease of pregnancy is the preferred approach and has been the subject of multiple trials with low-dose aspirin. The United States Preventive Services Task Force has released guidelines for use of low-dose aspirin to prevent pre- eclampsia,whichincreaseuseofthistherapybyexpansion of the patients whose condition is categorized at elevated risk for the development of this disorder. 49 In contrast, ACOG endorses a more restrained approach by recom

2017 Society for Maternal-Fetal Medicine

84. Obesity in pregnancy

Obesity in pregnancy 37 Obesity in pregnancy – Sandbjerg 2017 DSOG (Danish Society of Obstetrics and Gynecology) Approved on January 21 st , 2017 by the participants at the yearly obstetric guideline meeting in DSOG Recommendations: The recommendations in this guideline are generally for women with BMI (Body Mass Index) = 35 kg/m 2 . However, for some recommendations the studies with the underlying evidence have shown effects already at BMI = 30 kg/m 2 , and therefore this cut-off is used (...) in this guideline refers to “pre-pregnancy BMI”. This guideline has some overlap with other Danish national obstetric guidelines, e.g. “Gestational Diabetes Mellitus”, “Fetus Magnus Suspicious”, “Physical Activity in Pregnancy”, “Tromboprophylaxis”, “Vitamin D” and “Prolonged Pregnancy”. We therefore refer to these guidelines for further information. The recommendations in this guideline are in accordance with the recommendations from the Danish National Board of Health. Recommendations in pregnancy Strength

2017 Nordic Federation of Societies of Obstetrics and Gynecology

85. Interventions Targeting Sensory Challenges in Children with Autism Spectrum Disorder - An Update

. AHRQ or U.S. Department of Health and Human Services endorsement of any derivative products that may be developed from this report, such as clinical practice guidelines, other quality enhancement tools, or reimbursement or coverage policies, may not be stated or implied. This report may periodically be assessed for the currency of conclusions. If an assessment is done, the resulting surveillance report describing the methodology and findings will be found on the Effective Health Care Program Web

2017 Effective Health Care Program (AHRQ)

86. CRACKCast E101 – Stroke

arteritis Polyarteritis nodosa Lupus / vasculitis Cerebral venous sinus thrombosis Metabolic Hypoglycemia Wernicke’s encephalopathy (ophthalmoplegia, ataxia, confusion) Post-seizure induced Todd’s paralysis Infectious Bell’s palsy Labyrinthitis Vestibular neuronitis Demyelination or Peripheral Neuropathy Peripheral nerve palsy Demyelinating disease Meniere’s disease This is list is similar to the differential diagnosis of hemorrhagic stroke, but hemorrhagic stroke includes: Hypertensive encephalopathy (...) treatable cause for TIAs (eg. high-grade carotid stenosis, mural thrombus) should be sought, which would require in-hospital treatment such as anticoagulation, stenting, or carotid endarterectomy. Check out: As per the Canadian Best practise guidelines we should be starting patients with TIAs in the ED on antiplatelet therapy (as long as they have no contraindications). The NNT for this is 77. ASA alone if not currently on antiplatelet. Add second antiplatelet agent (eg. plavix plus ASA) if already

2017 CandiEM

87. CrackCAST E129 – Bacteria

support. Even with limited resources, mortality can be reduced to less than 50% with basic medication and experienced medical personnel. [7] List 5 differential diagnoses for Bell’s Palsy Common entities: CVA Trigeminal neuralgia Herpes zoster oticus (Ramsay Hunt syndrome) CNS tumour – acoustic neuroma; cerebellopontine angle lesions (meningioma); facial nerve schwanoma, parotid gland tumour, sarcoma Parotitis Malignant otitis externa Uncommon entities Cephalic tetanus Tick paralysis Botulism CN (...) palsies Due to cerebral aneurysms Amyloidosis GBS HIV Neurosyphillis Cephalic tetanus is especially difficult to diagnose when the cranial nerve palsy precedes trismus. The differential diagnosis of cephalic tetanus also includes Bell’s palsy, botulism, cranial nerve palsies, and facial cellulitis with facial nerve compression and ophthalmoplegia. [8] Describe 4 major components of management of tetanus There are no laboratory tests to confirm or to exclude the diagnosis of tetanus. Physical

2017 CandiEM

88. Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association Full Text available with Trip Pro

of childhood that leads to coronary artery aneurysms in ≈25% of untreated cases. It has been reported worldwide and is the leading cause of acquired heart disease in children in developed countries. Methods and Results: To revise the previous American Heart Association guidelines, a multidisciplinary writing group of experts was convened to review and appraise available evidence and practice-based opinion, as well as to provide updated recommendations for diagnosis, treatment of the acute illness, and long (...) might be required for selected patients. In 2004, the American Heart Association (AHA) published guidelines for the diagnosis, treatment, and long-term management of KD. The current scientific statement incorporates new evidence regarding underlying pathological processes, an algorithm to ensure capture of incomplete KD during the effective window of therapy, improved management of the acute illness that includes the use of additional therapies for IVIG-refractory patients, greater use of Z scores

2017 American Heart Association

89. Periviable Birth

in the proportion of children at age 30 months with severe or moderate impairment (defined as cerebral palsy, blindness, profound hearing loss, or developmental quotient 2 SDs or more below the mean) with increasing gestational age at birth: 45% at 22–23 weeks, 30% at 24 weeks, and 17% at 25 weeks of gestation ( ). Similarly, a recent systematic review found that the incidence of moderate-to-severe neurodevelopmental impairment among survivors at 4–8 years decreased progressively with each week gained (...) these outcome studies, it also should be emphasized that although summary data often are grouped into segments of weeks, outcomes for deliveries at the extreme may be closer to those of the adjacent week than to those at the other extreme of the same week (eg, outcomes at 23 6/7 weeks may be more similar to those at 24 0/7 weeks than to those at 23 0/7 weeks of gestation). Fig.1 . Percentage of survival by gestational age. * Stoll BJ, Hansen NI, Bell EF, Shankaran S, Laptook AR, Walsh MC, et al. Neonatal

2017 American College of Obstetricians and Gynecologists

90. Diagnosis and management of epilepsy in adults

Diagnosis and management of epilepsy in adults SIGN 143 • Diagnosis and management of epilepsy in adults A national clinical guideline Evidence May 2015 · Revised 2018KEY TO EVIDENCE STATEMENTS AND GRADES OF RECOMMENDATIONS LEVELS OF EVIDENCE 1 ++ High-quality meta-analyses, systematic reviews of RCTs, or RCTs with a very low risk of bias 1 + Well-conducted meta-analyses, systematic reviews, or RCTs with a low risk of bias 1 - Meta-analyses, systematic reviews, or RCTs with a high risk of bias (...) ; or Extrapolated evidence from studies rated as 2 + GOOD PRACTICE POINTS ? Recommended best practice based on the clinical experience of the guideline development group NHS Evidence has accredited the process used by Scottish Intercollegiate Guidelines Network to produce guidelines. Accreditation is applicable to guidance produced using the processes described in SIGN 50: a guideline developer’s handbook, 2008 edition ( More information on accreditation can

2015 SIGN

91. Let?s talk about protection: enhancing childhood vaccination uptake public health guidance

. If applicable, demonstrates ability to use registry or computer to call up patient record, assess what is due today, and update computer immunisation history. 4. Asks for and updates patient’s record of immunisations and reminds them to bring it to each visit. Some suggestions for action to improve skills include: a. Watch video on immunisation techniques. b. Review office protocols. c. Review manuals, textbooks, wall charts or other guides. d. Review package inserts. e. Review vaccine handling guidelines

2016 European Centre for Disease Prevention and Control - Public Health Guidance

92. Pandemic influenza vaccine H5N1 MedImmune

, colour, opalescence and appearance, sterility, and thermal stability. The analytical methods have been adequately described and (non-compendial methods) appropriately validated in accordance with ICH guidelines. Potency is determined with the fluorescent focus assay (see under active substance). The potential impurities in the P/LAIV finished product are endotoxin, ovalbumin and other egg-derived proteins, and residual process and excipient components (Gentamicin Sulfate), which are also present

2016 European Medicines Agency - EPARs

95. Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death Full Text available with Trip Pro

Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death We use cookies to enhance your experience on our website. By continuing to use our website, you are agreeing to our use of cookies. You can change your cookie settings at any time. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death | European Heart Journal | Oxford Academic Search Account Menu Menu Navbar Search Filter Mobile Microsite Search Term Close (...) search filter search input Article Navigation Close mobile search navigation Article navigation 1 November 2015 Article Contents Article Navigation 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC) Endorsed by: Association for European Paediatric and Congenital

2015 European Society of Cardiology

96. Stroke and Transient Ischemic Attack ? Acute and Long-Term Management

seizures, migraine with aura, syncope and vertigo due to peripheral vestibulopathies. When assessing the patient, look for signs and symptoms of vasculitis, sinusitis, mastoiditis and meningitis for a possible differential diagnosis or possible alternate etiology. Differential Diagnosis for Suspected Stroke: This includes seizures, tumours, abscesses, arteriovenous malformations, subdural hematomas, demyelination, focal encephalitis, vasculitis, Bell’s palsy, plexopathies, mononeuropathies and upper (...) Stroke and Transient Ischemic Attack ? Acute and Long-Term Management Guidelines & Protocols Advisory Committee Stroke and Transient Ischemic Attack – Acute and Long-Term Management Effective Date: April 1, 2015 Scope This guideline provides recommendations for the acute and long-term management of stroke and transient ischemic attack (TIA) in adults aged = 19 years, in the primary care setting. This includes secondary stroke/TIA prevention and medications. This guideline is part

2015 Clinical Practice Guidelines and Protocols in British Columbia

97. Hypertension in pregnancy

is based on the National Institute for Health and Care Excellence (NICE) guidance Hypertension in pregnancy: the management of hypertensive disorders in pregnancy [ ] and covers the management and referral of women during pregnancy and in the postpartum period. This topic also covers the management of proteinuria after 20 weeks' pregnancy, which is based on the Pre-eclampsia community guideline [ ]. This CKS topic does not cover the secondary care management of hypertension in pregnancy (...) in February 2015 to identify evidence-based guidelines, UK policy, systematic reviews, and key randomized controlled trials published since the last revision of this topic. The topic has undergone minor restructuring. No major changes to the recommendations have been made. Previous changes Previous changes November 2012 — minor update. The links to the electronic medicines website ( ) have been updated. August to November 2010 — topic updated. The evidence-base has been reviewed in detail

2019 NICE Clinical Knowledge Summaries

98. A systematic review of the clinical effectiveness and cost-effectiveness of sensory, psychological and behavioural interventions for managing agitation in older adults with dementia

Excellence (NICE) dementia guidelines recommended a range of non-pharmacological interventions, including aromatherapy, music therapy, dance therapy, animal-assisted therapy and multisensory stimulation, but the evidence for many of these is currently unclear. 20 A previous Health Technology Assessment (HTA)-commissioned systematic review found no conclusive evidence to justify recommending any non-pharmacological interventions for reducing wandering behaviour (which, as previously stated, may (...) adverse events and death. 21 Recent meta-analyses found modest bene?ts in the treatment of aggression (best evidence for risperidone, followed by aripiprazole) but increased risk of cerebrovascular events and death. 22–24 The 2006 NICE dementia guidelines recommend limiting the use of antipsychotic medication, for treating agitation in people with dementia, to those whose behaviour was causing signi?cant distress. 25 The use of both antipsychotics 26 and benzodiazepines 27 in dementia has been

2014 NIHR HTA programme

99. Acute pain management: scientific evidence (3rd Edition)

for his significant contribution to the web site development which underpinned the review process, and to Professor Michael Cousins for his advice and assistance throughout the development process. NHMRC approval These guidelines were approved by the NHMRC on 4 February 2010, under Section 14A of the National Health and Medical Research Council Act 1992. Approval for the guidelines by NHMRC is granted for a period not exceeding five years, at which date the approval expires. The NHMRC expects that all (...) guidelines will be reviewed no less than once every five years. Readers should check with the Australian and New Zealand College of Anaesthetists for any reviews or updates of these guidelines. Disclaimer This document aims to combine a review of the best available evidence for acute pain management with current clinical and expert practice, rather than to formulate specific clinical practice recommendations. It is designed to provide information based on the best evidence available at the time

2015 National Health and Medical Research Council

100. Late Effects of Treatment for Childhood Cancer (PDQ®): Health Professional Version

for cancer patients. It does not provide formal guidelines or recommendations for making health care decisions. This summary is reviewed regularly and updated as necessary by the PDQ Pediatric Treatment Editorial Board, which is editorially independent of the National Cancer Institute (NCI). The summary reflects an independent review of the literature and does not represent a policy statement of NCI or the National Institutes of Health (NIH). General Information About Late Effects of Treatment (...) Guidelines for Survivors of Childhood, Adolescent, and Young Adult Cancers To facilitate survivor and provider access to succinct information to guide risk-based care, COG investigators have organized a compendium of exposure- and risk-based health surveillance recommendations, with the goal of standardizing the care of childhood cancer survivors.[ ] The compendium of resources includes the following: Long-Term Follow-Up Guidelines. COG are appropriate for asymptomatic survivors presenting for routine

2018 PDQ - NCI's Comprehensive Cancer Database

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>